Integra LifeSciences | IART - 销售收入



金融业
股票价格
USD
资产
USD 3.58B
现金及等价物
USD 236.81M
销售成本
USD 178.71M
流动资产
USD 1.17B
流动负债
USD 346.85M
债务
USD 2.04B
EBIT
USD 11.47M
EBITDA
USD 76.18M
员工
4.4K
EPS每股收益
USD 0.54
股本和储备
USD 1.04B
销售毛利
USD 213.21M
债务利息支出
USD 22.47M
利息收入
USD 4.11M
贷款资金
USD 1.83B
市值
USD 1.37B
净收入
USD -4.62M
营业费用
USD 1.04B
营业利润
USD 11.47M
普通股股本
USD 77.82M
PE价格收益
5.07
税前利润
USD -2.41M
销售收入
USD 391.9M
销售和管理费用
USD 178.24M
股票
USD 495.04M
贸易债权人
USD 87.95M
应收帐款人
USD 264.41M


销售 更改 日
Abbott USD 11.16B 300M 2026-03
AtriCure USD 141.2M 700K 2026-03
Baxter International USD 2.7B 270M 2026-03
Becton, Dickinson and Co. USD 4.7B 600M 2026-03
Boston Scientific USD 5.2B 90M 2026-03
CONMED USD 317M 56.2M 2026-03
Cooper Companies USD 1.08B 57.4M 2026-03
Dexcom USD 1.19B 70M 2026-03
Edwards Lifesciences USD 1.65B 80M 2026-03
Globus Medical USD 759.85M 66.55M 2026-03
HeartBeam USD 0 0 2025-03
Insulet USD 761.7M 22.1M 2026-03
Integra LifeSciences USD 391.9M 43M 2026-03
Intuitive Surgical USD 2.77B 100M 2026-03
J&J USD 24.1B 500M 2026-03
Medtronic USD 9.8B 800M 2026-03
Merit Medical Systems USD 381.9M 12M 2026-03
Orthofix International USD 219.91M 14.28M 2025-12
Smith & Nephew USD 3.18B 353M 2025-12
Stryker USD 6B 1.2B 2026-03
Tandem Diabetes Care USD 247.22M 43.18M 2026-03
Teleflex USD 548.3M 20.68M 2026-03
Zimmer Biomet Holdings USD 2.09B 150M 2026-03